Mesoblast International Sàrl

Mesoblast International Sàrl, limited liability company in Genève (GE). Registration active in the commercial register since 2011. Latest publication: March 4, 2019. UID CHE-473.592.248.

Mesoblast is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. Its product candidates include RYONCIL™, Remestemcel-L, REVASCOR® and MPC-06-ID.¹

Commercial register

Legal form: Limited liability company Sàrl/GmbH
Registered office: c/o CSC Corporate Services (Suisse) Sàrl, succursale Genève Place des Alpes 4, 1201 Genève
Share capital: CHF 100,000
UID: CHE-473.592.248
Registered since: 2011
Former names: Mesoblast Switzerland SA
Registered purpose (original language): faciliter l'atteinte des objectifs commerciaux du groupe Mesoblast qui visent à développer et à commercialiser des séries de produits dérivés à marges élevées de cellules souches adultes brevetés, destinés dans le commerce à une utilisation dans une variété d'indications; aider spécifiquement à faciliter le développement de ces produits par la gestion de certaines recherches et du développement d'essais précliniques, essais cliniques, et approbations réglementaires (cf. statuts pour but complet). Show moreShow less

All 15 companies registered at this address

Similar companies

AB2 Bio SA Ecublens (VD) Manufacture of basic pharmaceutical products
GENFA GLOBAL LB (LABORATOIRES BIOPHARMACEUTIQUES) SA Le Grand-Saconnex
INFLAMALPS SA Monthey Scientific research and development
Incyte Biosciences Technical Operations Sàrl Yverdon-les-Bains Manufacture of basic pharmaceutical products
BioNOOX SA Lausanne Manufacture of basic pharmaceutical products
Signal26 Biotherapeutics SA Epalinges Manufacture of basic pharmaceutical products

A free account opens every company that looks like Mesoblast International Sàrl, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Officers changed March 4, 2019

Mesoblast International Sàrl, à Meyrin, CHE-473.592.248 (FOSC du 13.03.2018, p. 0/4109089). Nouvelle gérante: Costafrolaz Michèle, de France, à Genève avec signature individuelle.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.